Companies/DNAPrint Genomics, Inc.

Company profile

DNAPrint Genomics, Inc.

OTC: DNAG · Healthcare · Biotechnology

PublicHQ Sarasota, Reports USD

#768 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

——

FH —DQ —GM —SS 46

v0.1 · 5/100 weight · pillars only

↑ revenue growth (YoY), listing tenure · ↓ market scale, growth stability

Methodology →

Revenue TTM

$1.9M

Rev growth YoY (TTM)

-15.2%

Net income (FY)

-$12.3M

Employees

Market cap

$12.9k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$2.4M$2.4M2006

Net income-$12.3M-$12.3M2006

Operating income-$8.9M-$8.9M2006

Total assets$10.3M$10.3M2006

Liabilities$14.0M$14.0M2006

Equity-$3.7M-$3.7M2006

Revenue trend

FY2001 – FY2006 · USD

$14.4k

FY01

$184.6k

FY02

$709.6k

FY03

$785.6k

FY04

$1.3M

FY05

$2.4M

FY06

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

DNAPrint Genomics, Inc. booked $2.4M in FY2006 revenue, growing 91% year over year — faster than most Healthcare companies we track, at a -507.5% net margin.

Peers · Healthcare

That Marketing Solution, Inc.——Binovi Technologies Corp.——4Front Ventures Corp.——SmileDirectClub Inc Class A——

Key facts

CEOJatin Patel

SectorHealthcare

IndustryBiotechnology

HeadquartersSarasota, null

ExchangeOTC: DNAG

Employees24

IPO date2001-02-22

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.